Department of Nanobio Drug Discovery
School: Graduate School of Pharmaceutical
Background and aims
Recent advance in the field of engineering, especially nano, material, and analytical technology, is contributing to accumulate a huge amount of bio-information, such as genomic, genetic, epigenetic, and proteomic information. Currently, Drug discovery science is developing by combining the accumulated bio-information with novel analytical approaches, such as system biology. In addition, development of a novel nano-, material-, and analytical technology combined with bio-informatics will enable us to discover novel drugs and biomakers, and to create innovative diagnostic tools and therapeutic methods. "Nanobio" research, an integrated research between "nano"-material technology and "bio"-logy, will provide cutting-edge bio-information to the drug discovery science field. Furthermore, Nanobio approaches are expected to expand the range of research options in the medical and pharmacological field. Thus, goals of our department are to integrate nano-technology and bio-technology to elucidate normal vital functions and pathophysiologic mechanisms of diseases, and to establish novel diagnostic and therapeutic tools using the Nanobio technology.
Our department will be seeking our goals not only by ourselves, but also with intra- and inter-institutional collaborations. In addition, corroborations with industrial companies will accelerate research progress in terms of funding and sharing the cutting edge technologies. Thus, we will not hesitate to initiate academic-industrial collaborations, which will be a new trend for the researches in the academic institutions.